Combined administration of mitogenic immumo stimulator and a thy

Details Combined administration of mitogenic immumo stimulator and a thy Combined administration of mitogenic immumo stimulator and a thy

1995-07-24

1998-12-08

Minnifield, N. M.

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

4241951, 424568, 514 1, 514 12, 514 13, 514 14, 514 15, 514 16, 514 17, 514 18, 514 21, 514 23, 514 24, 514 53, 514 54, A61K 3100, A61K 39385, A61K 3555, A01N 6500

Patent

active

058465480

ABSTRACT:
A method of tumor therapy involves controlling the immune system by co-administration of a mitogenic immuno-stimulating substance and a thymomimetic substance.

REFERENCES:
patent: 3267090 (1966-08-01), Mueller
patent: 4529543 (1985-07-01), Renoux et al.
patent: 4548813 (1985-10-01), Lawson
Cupissol et al, 1981, C.R. Seances Soc. Biol. Ses Fil. 175(2):235-41 Abstract only.
Ganguly et al, Chemotherapy, 1994, 40:272-278.
Hajito et al, 1989, Cancer Res. 49:4803-4808.
Serrou et al, 1979, NYAS, 95-100.
Hajto, 1986, Oncology, 43 (suppl 1):51-65.
Kuttan et al, 1992, Cancer Letters, 66:123-130.
Umiel et al, 1978, Cellular Immunol, 37:134-141.
Kuttan et al, 1992. J. Expt. Clin. Cancer Res. 11(1):7-12.
Walzel et al, 1990, Folia Biologica (Praha), 36:181-187.
Jonas et al, 1992. Acta histochemica, (Suppl.-Band XLI, S):73-79.
Kuttan et al, 1988, Cancer Letters, 41:307-14.
von Laue et al, 1988, Deuusche Zeit. feur Onkelogie, 3:68-72.
Franz 1986, Onocology 43 (Suppl. 1):23-34.
Wannagat 1991 Reflections on Cancer Therapy.
Mater. Med. Pol. 23(4):249-250.
Evett et al. 1986. Biological Properties of Pyrularia thionin . . . Toxicon 24(6):622-25.
Dillman et al. 1987. Phase II Trial of Thymosin Frachion 5 . . . J. Biol Resp. Modifiers. 6:263-267.
Irimajuiri et al. 1979 Effect of Ok 432 and Thymosin . . . Med. J. Kinki Univ. 4(2):191-199 Abstract only.
Hadden et al. 1989. Therapy of secondary T-cell immuno-deficiencies with . . . Med. Oncol. & Tumor Pharmacother. 6(1):11-17.
Nedwin et al. 1985. Effect of Interleukin 2, Interferon--8, and mitogens . . . J. Immunol. 135(4):2492-97..
Aymon. 1990. Mistletoe in advanced cancer. Cancer Journal. 3(3):123.
Umil et al (1978) Cell Immunol. 37(1):134-141, Abstract only.
Hauser (1989) Schweiz Rundsch Meu Prax 78(17): 498-506, Abstract only.
Kienle (1981) Z FA (Syottgart) 57(5):328-337, Abstract only.
Leroi (1979) Krebsgeschehen 11(5):145-146, Abstract only.
Franz (1985) Pharmazie (40,2 97-104), Abstract only.

Affiliated with

Also associated with

Rating

Combined administration of mitogenic immumo stimulator and a thy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined administration of mitogenic immumo stimulator and a thy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined administration of mitogenic immumo stimulator and a thy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-174655